|
Barrier Therapeutics, Inc. - Company Profile Snapshot
| Company Profile: |
Barrier Therapeutics, Inc. |
| Ticker: |
BTRX |
| Exchanges: |
NAS |
| 2007 Sales: |
24,082,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Service Organizations |
| Country: |
UNITED STATES |
| Employees: |
130 |
Business Description
Barrier Therapeutics, Inc.. The Group's principal activity is the discovery, development and commercialization of a portfolio of innovative pharmaceutical products to address major medical needs in the field of dermatology. Currently it has multiple product candidates in clinical development, with four of these candidates in or entering Phase III clinical trials. Its advanced product candidates are Sebazole, Zimycan, Hyphanox and Liarozole. Its trademarks are Barrier TherapeuticsTM, SebazoleTM, ZimycanTM, HyphanoxTM, RambazoleTM and HivenylTM. The Group operates in the United States.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
